Search Results - "Semb, Anne G"

Carotid Plaque Characteristics and Disease Activity in Rheumatoid Arthritis by SEMB, Anne G, ROLLEFSTAD, Silvia, PROVAN, Sella A, KVIEN, Tore K, STRANDEN, Einar, OLSEN, Inge C, HISDAL, Jonny

“…Carotid plaques (CP) are predictive of acute coronary syndrome in patients with rheumatoid arthritis (RA), suggesting that atherosclerotic plaques in these…”
Get full text

Physical Fitness in Patients With Ankylosing Spondylitis: Comparison With Population Controls by Halvorsen, Silje, Vøllestad, Nina K, Fongen, Camilla, Provan, Sella A, Semb, Anne G, Hagen, Kåre B, Dagfinrud, Hanne

“…Although flexibility traditionally has been the main focus for physical therapy in patients with ankylosing spondylitis (AS), there is now evidence for an…”
Get full text

Smoking cessation intervention for reducing disease activity in chronic autoimmune inflammatory joint diseases by Roelsgaard, Ida K, Esbensen, Bente A, Østergaard, Mikkel, Rollefstad, Silvia, Semb, Anne G, Christensen, Robin, Thomsen, Thordis

“…Chronic inflammatory joint diseases (IJDs) affect 1% to 2% of the population in developed countries. IJDs include rheumatoid arthritis (RA), ankylosing…”
Get more information

Could cardiovascular disease risk stratification and management in rheumatoid arthritis be enhanced? by Dessein, Patrick H, Semb, Anne G

Get more information

Left Ventricular Systolic Myocardial Function in Ankylosing Spondylitis by Midtbø, Helga, Semb, Anne G., Matre, Knut, Rollefstad, Silvia, Berg, Inger J., Gerdts, Eva

“…Objective Subclinical left ventricular (LV) myocardial dysfunction is associated with an increased risk of cardiovascular disease (CVD), but it is not known…”
Get full text

Intensive lipid lowering in patients with rheumatoid arthritis and previous myocardial infarction: an explorative analysis from the incremental decrease in endpoints through aggressive lipid lowering (IDEAL) trial by SEMB, Anne G, HOLME, Ingar, KVIEN, Tore K, PEDERSEN, Terje R

“…Documentation on secondary prevention with statins in RA patients with coronary heart disease (CHD) is limited, despite the increased risk of CHD in RA. Our…”
Get full text

Advancing medical education—a brief report by the ESC Working Group on Cardiovascular Pharmacotherapy by Kaski, Juan C, Semb, Anne G, Savarese, Gianluigi

Get full text

Strategies for implementation of guideline recommended cardiovascular risk management for patients with rheumatoid arthritis: results from a questionnaire survey of expert rheumatology centers by Weijers, Julia M., Semb, Anne G., Rollefstad, Silvia, Kitas, George D., van Riel, Piet L. C. M.

“…The aim was to study the different strategies used to implement cardiovascular risk evaluation and management for patients with rheumatoid arthritis (RA) in…”
Get full text

Osteoprotegerin and Soluble Receptor Activator of Nuclear Factor-κB Ligand and Risk for Coronary Events: A Nested Case–Control Approach in the Prospective EPIC-Norfolk Population Study 1993–2003 by Semb, Anne G, Ueland, Thor, Aukrust, Pål, Wareham, Nicholas J, Luben, Robert, Gullestad, Lars, Kastelein, John J.P, Khaw, Kay-Tee, Boekholdt, S Matthijs

“…OBJECTIVE—The purpose of this study was to examine the association between serum levels of osteoprotegerin (OPG) and receptor activator of nuclear factor-κB…”
Get full text

Enhanced T-Cell Expression of RANK Ligand in Acute Coronary Syndrome: Possible Role in Plaque Destabilization by Sandberg, Wiggo J, Yndestad, Arne, Øie, Erik, Smith, Camilla, Ueland, Thor, Ovchinnikova, Olga, Robertson, Anna-Karin L, Müller, Fredrik, Semb, Anne G, Scholz, Hanne, Andreassen, Arne K, Gullestad, Lars, Damås, Jan Kristian, Frøland, Stig S, Hansson, Göran K, Halvorsen, Bente, Aukrust, Pål

“…OBJECTIVE—Based on its role in inflammation and matrix degradation, we hypothesized a role for osteoprotegerin (OPG), RANK, and RANK ligand (RANKL) in coronary…”
Get full text

Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors by WAEHRE, Torgun, YNDESTAD, Arne, SMITH, Camilla, HAUG, Terje, TUNHEIM, Siv Haugen, GULLESTAD, Lars, FRØLAND, Stig S, SEMB, Anne G, AUKRUST, Pal, DAMAS, Jan K

“…Inflammation is important in atherogenesis. Interleukin (IL)-1 is the prototypic inflammatory cytokine. We hypothesized a dysbalance between inflammatory and…”
Get full text

Enhanced Cardiovascular Risk in Rheumatoid Arthritis: Elucidation, Assessment, and Management by Dessein, Patrick H., Semb, Anne G., González-Gay, Miguel A., Popa, Calin D.

“…[...]data on the impact of JIA on CVD risk remain limited. [...]they recently established a structured arthritis clinic (AC)…”
Get full text

Hydroxymethylglutaryl coenzyme a reductase inhibitors down-regulate chemokines and chemokine receptors in patients with coronary artery disease by Wæhre, Torgun, Damås, Jan K, Gullestad, Lars, Holm, Are M, Pedersen, Terje R, Arnesen, Kjell E, Torsvik, Harald, Frøland, Stig S, Semb, Anne G, Aukrust, P.ål

“…We sought to investigate whether the activation of the chemokine network observed in patients with coronary artery disease (CAD) could be modified by treatment…”
Get full text

Raised serum levels of soluble CD40 ligand in patients with familial hypercholesterolemia: downregulatory effect of statin therapy by Semb, Anne G, van Wissen, Sanne, Ueland, Thor, Smilde, Tineke, Waehre, Torgun, Tripp, Mieke D, Frøland, Stig S, Kastelein, John J.P, Gullestad, Lars, Pedersen, Terje R, Aukrust, P.ål, Stalenhoef, Anton F.H

“…In the present study, we investigated the effects of statins on serum levels of soluble CD40 ligand (sCD40L) in patients with familial hypercholesterolemia…”
Get full text

Chemokines in Children With Heterozygous Familiar Hypercholesterolemia: Selective Upregulation of RANTES by Holven, Kirsten B, Damås, Jan K, Yndestad, Arne, Wæhre, Torgun, Ueland, Thor, Halvorsen, Bente, Heggelund, Lars, Sandberg, Wiggo J, Semb, Anne G, Frøland, Stig S, Ose, Leiv, Nenseter, Marit S, Aukrust, Pål

“…OBJECTIVE—Increasing data support the involvement of chemokines in atherogenesis. However, although several studies have shown increased chemokine levels in…”
Get full text

Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment by Choy, Ernest, Ganeshalingam, Kandeepan, Semb, Anne Grete, Szekanecz, Zoltán, Nurmohamed, Michael

“…Risk of cardiovascular (CV) disease is increased among RA patients. High inflammatory burden associated with RA appears to be a key driver of the increased…”
Get full text

Cardiovascular disease risk profiles in inflammatory joint disease entities by Wibetoe, Grunde, Ikdahl, Eirik, Rollefstad, Silvia, Olsen, Inge C, Bergsmark, Kjetil, Kvien, Tore K, Salberg, Anne, Soldal, Dag Magnar, Bakland, Gunnstein, Lexberg, Åse, Fevang, Bjørg-Tilde, Gulseth, Hans Christian, Haugeberg, Glenn, Semb, Anne Grete

“…Patients with inflammatory joint diseases (IJD) have increased risk of cardiovascular disease (CVD). Our aim was to compare CVD risk profiles in patients with…”
Get full text

Rosuvastatin improves endothelial function in patients with inflammatory joint diseases, longitudinal associations with atherosclerosis and arteriosclerosis: results from the RORA-AS statin intervention study by Ikdahl, Eirik, Hisdal, Jonny, Rollefstad, Silvia, Olsen, Inge C, Kvien, Tore K, Pedersen, Terje R, Semb, Anne Grete

“…Endothelial dysfunction is an early step in the atherosclerotic process and can be quantified by flow-mediated vasodilation (FMD). Our aim was to investigate…”
Get full text

Hand, hip and knee osteoarthritis in a Norwegian population-based study--the MUST protocol by Østerås, Nina, Risberg, May Arna, Kvien, Tore K, Engebretsen, Lars, Nordsletten, Lars, Bruusgaard, Dag, Schjervheim, Unni-Berit, Haugen, Ida K, Hammer, Hilde Berner, Provan, Sella, Øiestad, Britt Elin, Semb, Anne Grete, Rollefstad, Silvia, Hagen, Kåre Birger, Uhlig, Till, Slatkowsky-Christensen, Barbara, Kjeken, Ingvild, Flugsrud, Gunnar, Grotle, Margreth, Sesseng, Sølve, Edvardsen, Hanne, Natvig, Bård

“…Knowledge about the prevalence and consequences of osteoarthritis (OA) in the Norwegian population is limited. This study has been designed to gain a greater…”
Get full text

Osteoprotegerin and soluble receptor activator of nuclear factor-kappaB ligand and risk for coronary events: a nested case-control approach in the prospective EPIC-Norfolk population study 1993-2003 by Semb, Anne G, Ueland, Thor, Aukrust, Pål, Wareham, Nicholas J, Luben, Robert, Gullestad, Lars, Kastelein, John J P, Khaw, Kay-Tee, Boekholdt, S Matthijs

“…The purpose of this study was to examine the association between serum levels of osteoprotegerin (OPG) and receptor activator of nuclear factor-kappaB ligand…”
Get full text